Arvind Remedies Ltd. - Research Center
531823 ARVINDREM Group (Z) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 16 | Jun ' 15 | Mar ' 15 | Mar ' 14 | Mar ' 13 | |
|---|---|---|---|---|---|
| Sales | 10.80 | 787.07 | 774.93 | 911.11 | 664.26 |
| Operating profit | -94.85 | -43.15 | -41.39 | 176.94 | 133.73 |
| Interest | 1.02 | 71.07 | 74.84 | 77.10 | 59.19 |
| Gross profit | -92.33 | -108.36 | -110.37 | 100.30 | 75.14 |
| EPS (Rs) | -16.34 | -46.98 | -46.41 | 8.65 | 8.42 |
Annual
results in details
| Mar ' 16 | Jun ' 15 | Mar ' 15 | Mar ' 14 | Mar ' 13 | |
|---|---|---|---|---|---|
| Other income | 3.53 | 5.86 | 5.86 | 0.47 | 0.59 |
| Stock adjustment | 0.23 | 46.45 | -150.67 | -9.27 | -2.39 |
| Raw material | 7.85 | 657.46 | 844.38 | 690.88 | 494.98 |
| Power and fuel | 0.35 | 3.14 | 2.97 | 3.49 | 3.35 |
| Employee expenses | 2.80 | 15.99 | 14.71 | 17.41 | 13.44 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 94.42 | 107.18 | 104.93 | 31.66 | 21.15 |
| Provisions made | - | - | - | - | - |
| Depreciation | 18.98 | 29.46 | 23.57 | 13.90 | 12.59 |
| Taxation | - | -5.24 | -5.24 | 27.55 | 21.93 |
| Net profit / loss | -111.32 | -320.04 | -316.16 | 58.90 | 40.62 |
| Extra ordinary item | - | -187.46 | -187.46 | - | - |
| Prior year adjustments | - | - | - | 0.06 | - |
| Equity capital | 68.13 | 68.13 | 68.13 | 68.13 | 48.23 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 656.90 | 656.90 | 656.90 | 434.98 | 256.39 |
| Agg.of non promotoholding (%) | 96.42 | 96.42 | 96.42 | 63.85 | 53.16 |
| OPM (%) | -878.46 | -5.48 | -5.34 | 19.42 | 20.13 |
| GPM (%) | -644.42 | -13.67 | -14.14 | 11.00 | 11.30 |
| NPM (%) | -776.91 | -40.36 | -40.49 | 6.46 | 6.11 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis